Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 21, 2012 08:01 ET | Source: Pathfinder Cell Therapy, Inc.

Pathfinder Presents Preliminary Data on New Regenerative Approach to Diabetes Treatment

CAMBRIDGE, Mass., Feb. 21, 2012 (GLOBE NEWSWIRE) -- Pathfinder Cell Therapy, Inc. ("Pathfinder," or "the Company") (OTCQB:PFND), a biotechnology company focused on the treatment of diabetes and other...
February 16, 2012 08:00 ET | Source: Pathfinder Cell Therapy, Inc.

Pathfinder to Present at New York Stem Cell Summit

CAMBRIDGE, Mass., Feb. 16, 2012 (GLOBE NEWSWIRE) -- Pathfinder Cell Therapy, Inc. ("Pathfinder," or "the Company") (OTCQB:PFND), a biotechnology company focused on the treatment of diseases...
February 15, 2012 08:00 ET | Source: Pathfinder Cell Therapy, Inc.

Pathfinder Announces First European Patent Allowance for Pathfinder Cells

CAMBRIDGE, Mass., Feb. 15, 2012 (GLOBE NEWSWIRE) -- Pathfinder Cell Therapy, Inc. ("Pathfinder," or "the Company") (OTCQB:PFND), a biotechnology company focused on the treatment of diseases...
December 13, 2011 10:00 ET | Source: Pathfinder Cell Therapy, Inc.

Pathfinder Cell Therapy Provides Update on Pathfinder Cell Research and Development

CAMBRIDGE, Mass., Dec. 13, 2011 (GLOBE NEWSWIRE) -- Pathfinder Cell Therapy, Inc. ("Pathfinder") (OTCQB:PFND), a biotechnology company focused on the treatment of diseases characterized by...